Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F75010330%3A_____%2F12%3A00009881" target="_blank" >RIV/75010330:_____/12:00009881 - isvavai.cz</a>

Result on the web

<a href="http://dx.doi.org/10.5588/ijtld.11.0542" target="_blank" >http://dx.doi.org/10.5588/ijtld.11.0542</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5588/ijtld.11.0542" target="_blank" >10.5588/ijtld.11.0542</a>

Result language

angličtina

Original language name

Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs

Original language description

Based on data from 14 Supranational Tuberculosis (TB) Reference Laboratories worldwide, the proportion of rifampicin (RMP) resistant isolates that were isoniazid (INH) susceptible by phenotypic drug susceptibility testing varied widely (0.5-11.6%). RMP resistance is not always a good proxy for a presumptive diagnosis of multidrug-resistant TB, which has implications for use of molecular assays that identify only RMP resistance-associated DNA mutations. .

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FN - Epidemiology, infection diseases and clinical immunology

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2012

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

International journal of tuberculosis and lung disease

ISSN

1027-3719

e-ISSN

—

Volume of the periodical

16

Issue of the periodical within the volume

3

Country of publishing house

FR - FRANCE

Number of pages

3

Pages from-to

355-357

UT code for WoS article

000301097500013

EID of the result in the Scopus database

—